1. Home
  2. HVT vs ALLO Comparison

HVT vs ALLO Comparison

Compare HVT & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HVT
  • ALLO
  • Stock Information
  • Founded
  • HVT 1885
  • ALLO 2017
  • Country
  • HVT United States
  • ALLO United States
  • Employees
  • HVT N/A
  • ALLO N/A
  • Industry
  • HVT Other Specialty Stores
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HVT Consumer Discretionary
  • ALLO Health Care
  • Exchange
  • HVT Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • HVT 363.1M
  • ALLO 431.9M
  • IPO Year
  • HVT N/A
  • ALLO 2018
  • Fundamental
  • Price
  • HVT $21.69
  • ALLO $1.87
  • Analyst Decision
  • HVT Strong Buy
  • ALLO Buy
  • Analyst Count
  • HVT 1
  • ALLO 12
  • Target Price
  • HVT $45.00
  • ALLO $10.06
  • AVG Volume (30 Days)
  • HVT 150.2K
  • ALLO 2.7M
  • Earning Date
  • HVT 02-19-2025
  • ALLO 11-07-2024
  • Dividend Yield
  • HVT 5.81%
  • ALLO N/A
  • EPS Growth
  • HVT N/A
  • ALLO N/A
  • EPS
  • HVT 1.60
  • ALLO N/A
  • Revenue
  • HVT $749,290,000.00
  • ALLO $43,000.00
  • Revenue This Year
  • HVT N/A
  • ALLO N/A
  • Revenue Next Year
  • HVT $6.06
  • ALLO N/A
  • P/E Ratio
  • HVT $13.54
  • ALLO N/A
  • Revenue Growth
  • HVT N/A
  • ALLO 26.47
  • 52 Week Low
  • HVT $21.14
  • ALLO $1.78
  • 52 Week High
  • HVT $37.05
  • ALLO $5.78
  • Technical
  • Relative Strength Index (RSI)
  • HVT 37.15
  • ALLO 36.24
  • Support Level
  • HVT $22.40
  • ALLO $1.83
  • Resistance Level
  • HVT $23.37
  • ALLO $2.12
  • Average True Range (ATR)
  • HVT 0.75
  • ALLO 0.16
  • MACD
  • HVT -0.16
  • ALLO -0.02
  • Stochastic Oscillator
  • HVT 18.91
  • ALLO 12.16

About HVT Haverty Furniture Companies Inc.

Haverty Furniture Companies Inc is a specialty retailer of residential furniture and accessories. It provides various products such as Sofa Tables, Sleepers, End Tables, Cocktail Tables, Accent Pieces, Display Cabinets, Wall Decor, floral and Tress, and other related products. The company operates primarily in the Southern and Midwestern U.S. All its activities are encompassed in its Merchandise division. The company derives the majority of its revenue from its upholstery products and, secondarily, from bedroom furniture.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, primarily generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: